Israeli American serial entrepreneur Dr. Micha Breakstone says advances in artificial intelligence and data generation are pushing biology toward a new era of predictive engineering, with major implications for regenerative medicine and disease treatment.

In an interview on the Jerusalem Post's Business and Innovation podcast, recorded shortly after his arrival in Israel, Breakstone discussed his transition from conversational AI to founding Cellular Intelligence, a tech bio company focused on understanding how cells respond to signals and change states.

Edited and produced by Gadi Zaig and Shifra Jacobs.